Biotechnology - Boston, Massachusetts, United States
ConquerX is developing the next-generation medical device for molecular diagnostics, the Metachip. ConquerX's Metachip technology represents a game-changing approach to cancer diagnostics and screening by leveraging a new class of biomarkers - microRNAs - to earlier detect up to eighteen types of cancer in one simple, accurate, cost-effective blood test.
Apache
Mobile Friendly